Prior to the establishment of the research consortium, Elekta, Philips and the University Medical Center Utrecht built and tested a prototype system that integrates a linear accelerator and a 1.5 Tesla MRI system. The success of these efforts enabled the project to move to the next phase of development and testing by the growing select group of consortium partners.Radiation therapy and medical imaging already play an essential role in treatment planning, delivery and after care, and are proven, cost-effective and safe methods for the treatment of individuals with cancer. Radiotherapy is a critical modality for cancer treatment, either as a frontline treatment or used with other modalities, such as chemotherapy. The procedure involves identifying cancerous tissue and irradiating it with high-energy radiation beams in a way that maximizes sparing of healthy tissues near the tumor. The integrated MRI-guided radiation therapy system is in development and not available for sale. For further information, please contact: Johan Andersson, Director, Investor Relations, Elekta ABTel: +46 702 100 451, email: firstname.lastname@example.org Time zone: CET: Central European Time Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, email: email@example.comTime zone: ET: Eastern Time Steve Klink, Philips Corporate CommunicationsTel: +31 20 5977415, email: firstname.lastname@example.org About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.